Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes

James A. de Lemos; Michael A. Blazing; Stephen D. Wiviott; Eldrin F. Lewis; Keith A.A. Fox; Harvey D. White; Jean‐Lucien Rouleau; Terje R. Pedersen; Laura H. Gardner; Robin Mukherjee; Karen E. Ramsey; Joanne Palmisano; David W. Bilheimer; Marc A. Pfeffer; Robert M. Califf; Eugene Braunwald; for the ASTEROID Investigators

doi:10.1001/jama.292.11.1307

Abstract

2][3] More recently, 2 ran-domized controlled trials have evaluated earlier initiation of statin therapy following an ACS event and have noted a corresponding early reduction in major cardiovascular events. 5,

Keywords

SimvastatinMedicineAcute coronary syndromePlaceboInternal medicineRegimenMyocardial infarctionStatinGastroenterology

Affiliated Institutions

The University of Texas Southwestern Medical Center US

Related Publications

Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

David A. Morrow , James A. de Lemos , Marc S. Sabatine +6 more

Background— Elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with higher risk of adverse outcomes in patients at risk for or with established corona...

2006 Circulation 311 citations

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

Rory Collins , Jane Armitage , Sarah Parish +2 more

Individuals with diabetes are at increased risk of cardiovascular morbidity and mortality, although typically their plasma concentrations of LDL cholesterol are similar to those...

2003 The Lancet 2888 citations

Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes

Salim Yusuf , Shamir R. Mehta , Feng Zhao +6 more

Background— The risk of ischemic events is high, both early and late after acute coronary syndromes (ACS). We examine the benefits and risks associated with the use of adding cl...

2003 Circulation 302 citations

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Christopher P. Cannon , Eugene Braunwald , Carolyn H. McCabe +7 more

Among patients who have recently had an acute coronary syndrome, an intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular eve...

2004 New England Journal of Medicine 4868 citations

Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes

Cynthia A. Jackevicius

Elderly patients with and without recent ACS have low rates of adherence to statins. This suggests that many patients initiating statin therapy may receive no or limited benefit...

2002 JAMA 1076 citations

Publication Info

Year: 2004
Type: article
Volume: 292
Issue: 11
Pages: 1307-1307
Citations: 1317
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1317

OpenAlex

Cite This

APA Style

                            
                                
                                    James A. de Lemos, 
                                
                                    Michael A. Blazing, 
                                
                                    Stephen D. Wiviott
                                
                                et al.
                            
                            (2004). 
                            Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes. 
                            JAMA
                            , 292
                            (11)
                            , 1307-1307.
                            https://doi.org/10.1001/jama.292.11.1307
                        

Identifiers

DOI: 10.1001/jama.292.11.1307